PowerUp Acquisition Corp.

    PowerUp Acquisition Corp.

    NNASDAQ:PWUP
    9.24
    USD
    0.00
    (0.00%)
    39.35P/E
    2021 Y
    2022 Y
    2023 Y
    TTM
    Revenue per Share
    - -
    - -
    - -
    - -
    Basic EPS, GAAP
    - -
    0.11
    0.23
    -0.45
    Free Cash Flow per Basic Share
    - -
    -0.04
    -0.03
    -0.35
    Dividend per Share
    - -
    - -
    - -
    - -
    Book Value per Share
    - -
    9.12
    0.45
    -1.04
    Tangible Book Value per Share
    - -
    9.12
    1.02
    0.01
    Basic Weighted Avg Shares
    - -
    32
    19
    8
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    - -
    - -
    Depreciation Expense
    - -
    - -
    - -
    - -
    Net Income, GAAP
    - -
    3
    4
    -4
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    - -
    - -
    - -
    Working Capital
    - -
    1
    - -
    -7
    LT Debt
    - -
    - -
    - -
    - -
    Total Equity
    - -
    289
    20
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    2.31
    3.01
    - -
    Return on Common Equity (%)
    - -
    - -
    3
    2.41

    Capital Structure

    USD

    •

    in mil. unless spec.
    Mar'24
    Jun'24
    Sep'24
    ST Debt
    2
    5
    5
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    9
    8
    8
    Market Capitalization
    138
    99
    103

    Working Capital

    USD

    •

    in mil. unless spec.
    Mar'24
    Jun'24
    Sep'24
    Total Current Assets
    - -
    - -
    - -
    Cash, Cash Equivalents & STI
    - -
    - -
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    3
    6
    7
    Payables & Accruals
    1
    1
    1
    ST Debt
    2
    5
    5
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    - -
    -93.23%
    Free Cash Flow
    - -
    - -
    -53.64%
    Net Income, GAAP
    - -
    - -
    33.65%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -0.01
    0.02
    0.03
    - -
    0.11
    2023
    0.08
    0.09
    -0.01
    - -
    0.23
    2024
    -0.27
    -0.07
    -0.07
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • accessnewswire.com

      Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq

    • accessnewswire.com

      Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq

    • prnewswire.com

      SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers of PWUP and ESGR

    • accesswire.com

      SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers of PWUP, ESGR

    • globenewswire.com

      Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements

    • globenewswire.com

      Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.

    • globenewswire.com

      PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

    • globenewswire.com

      PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders